Cargando…

Primary tumor resection with or without metastasectomy for left- and right-sided stage IV colorectal cancer: an instrumental variable analysis

BACKGROUND: Whether primary tumor location (PTL) is predictive of survival benefits following primary tumor resection plus metastasectomy (PMTR) and primary tumor resection (PTR) alone in stage IV colorectal cancer patients is not known. We sought to address this issue by employing instrumental vari...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Yi-Chen, Chen, Jun-Quan, Yin, Ling, Lin, Wu-Hao, Peng, Jian-Hong, Fan, Wen-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908621/
https://www.ncbi.nlm.nih.gov/pubmed/35264117
http://dx.doi.org/10.1186/s12876-022-02184-2
_version_ 1784665915095252992
author Yao, Yi-Chen
Chen, Jun-Quan
Yin, Ling
Lin, Wu-Hao
Peng, Jian-Hong
Fan, Wen-Hua
author_facet Yao, Yi-Chen
Chen, Jun-Quan
Yin, Ling
Lin, Wu-Hao
Peng, Jian-Hong
Fan, Wen-Hua
author_sort Yao, Yi-Chen
collection PubMed
description BACKGROUND: Whether primary tumor location (PTL) is predictive of survival benefits following primary tumor resection plus metastasectomy (PMTR) and primary tumor resection (PTR) alone in stage IV colorectal cancer patients is not known. We sought to address this issue by employing instrumental variable analysis to evaluate the efficacy of PMTR and PTR with stratification for primary tumor location in stage IV colorectal cancer patients. PATIENTS AND METHODS: Stage IV colorectal cancer patients diagnosed between January 1, 2005 and December 31, 2015 were identified from the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. To account for both measured and unmeasured confounders, the efficacy of PMTR and PTR in the left- and right-sided subgroups was evaluated using instrumental variable analysis, with the health service area as the instrument variable. Overall survival (OS) was the primary outcome of interest. RESULTS: A total of 50,333 eligible patients were analyzed (left-sided, n = 29,402 and right-sided, n = 20,931). OS was significantly better with PMTR than with other treatments (PTR, metastasectomy only, or no surgery) in patients with left-sided tumors (hazard ratio [HR] = 0.37 [95% CI 0.24–0.58], P < 0.001), but not in patients with right-sided tumors (HR = 0.98 [95% CI 0.65–1.47], P = 0.910; interaction test P < 0.001). OS was comparable in patients treated with PTR and those treated with no surgery in both the left-sided (HR = 1.11 [95% CI 0.68–1.81], P = 0.690) and right-sided (HR = 0.85 [95% CI 0.50–1.43], P = 0.530; interaction test P = 0.466) subgroups. CONCLUSIONS: PMTR appears to only benefit patients with left-sided stage IV colorectal cancer but not those with right-sided tumors. PTR does not improve OS, regardless of primary tumor location. When selecting patients for PMTR, primary tumor location should be considered. Overuse of PTR should be avoided. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-022-02184-2.
format Online
Article
Text
id pubmed-8908621
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89086212022-03-18 Primary tumor resection with or without metastasectomy for left- and right-sided stage IV colorectal cancer: an instrumental variable analysis Yao, Yi-Chen Chen, Jun-Quan Yin, Ling Lin, Wu-Hao Peng, Jian-Hong Fan, Wen-Hua BMC Gastroenterol Research BACKGROUND: Whether primary tumor location (PTL) is predictive of survival benefits following primary tumor resection plus metastasectomy (PMTR) and primary tumor resection (PTR) alone in stage IV colorectal cancer patients is not known. We sought to address this issue by employing instrumental variable analysis to evaluate the efficacy of PMTR and PTR with stratification for primary tumor location in stage IV colorectal cancer patients. PATIENTS AND METHODS: Stage IV colorectal cancer patients diagnosed between January 1, 2005 and December 31, 2015 were identified from the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. To account for both measured and unmeasured confounders, the efficacy of PMTR and PTR in the left- and right-sided subgroups was evaluated using instrumental variable analysis, with the health service area as the instrument variable. Overall survival (OS) was the primary outcome of interest. RESULTS: A total of 50,333 eligible patients were analyzed (left-sided, n = 29,402 and right-sided, n = 20,931). OS was significantly better with PMTR than with other treatments (PTR, metastasectomy only, or no surgery) in patients with left-sided tumors (hazard ratio [HR] = 0.37 [95% CI 0.24–0.58], P < 0.001), but not in patients with right-sided tumors (HR = 0.98 [95% CI 0.65–1.47], P = 0.910; interaction test P < 0.001). OS was comparable in patients treated with PTR and those treated with no surgery in both the left-sided (HR = 1.11 [95% CI 0.68–1.81], P = 0.690) and right-sided (HR = 0.85 [95% CI 0.50–1.43], P = 0.530; interaction test P = 0.466) subgroups. CONCLUSIONS: PMTR appears to only benefit patients with left-sided stage IV colorectal cancer but not those with right-sided tumors. PTR does not improve OS, regardless of primary tumor location. When selecting patients for PMTR, primary tumor location should be considered. Overuse of PTR should be avoided. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-022-02184-2. BioMed Central 2022-03-09 /pmc/articles/PMC8908621/ /pubmed/35264117 http://dx.doi.org/10.1186/s12876-022-02184-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Yao, Yi-Chen
Chen, Jun-Quan
Yin, Ling
Lin, Wu-Hao
Peng, Jian-Hong
Fan, Wen-Hua
Primary tumor resection with or without metastasectomy for left- and right-sided stage IV colorectal cancer: an instrumental variable analysis
title Primary tumor resection with or without metastasectomy for left- and right-sided stage IV colorectal cancer: an instrumental variable analysis
title_full Primary tumor resection with or without metastasectomy for left- and right-sided stage IV colorectal cancer: an instrumental variable analysis
title_fullStr Primary tumor resection with or without metastasectomy for left- and right-sided stage IV colorectal cancer: an instrumental variable analysis
title_full_unstemmed Primary tumor resection with or without metastasectomy for left- and right-sided stage IV colorectal cancer: an instrumental variable analysis
title_short Primary tumor resection with or without metastasectomy for left- and right-sided stage IV colorectal cancer: an instrumental variable analysis
title_sort primary tumor resection with or without metastasectomy for left- and right-sided stage iv colorectal cancer: an instrumental variable analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908621/
https://www.ncbi.nlm.nih.gov/pubmed/35264117
http://dx.doi.org/10.1186/s12876-022-02184-2
work_keys_str_mv AT yaoyichen primarytumorresectionwithorwithoutmetastasectomyforleftandrightsidedstageivcolorectalcanceraninstrumentalvariableanalysis
AT chenjunquan primarytumorresectionwithorwithoutmetastasectomyforleftandrightsidedstageivcolorectalcanceraninstrumentalvariableanalysis
AT yinling primarytumorresectionwithorwithoutmetastasectomyforleftandrightsidedstageivcolorectalcanceraninstrumentalvariableanalysis
AT linwuhao primarytumorresectionwithorwithoutmetastasectomyforleftandrightsidedstageivcolorectalcanceraninstrumentalvariableanalysis
AT pengjianhong primarytumorresectionwithorwithoutmetastasectomyforleftandrightsidedstageivcolorectalcanceraninstrumentalvariableanalysis
AT fanwenhua primarytumorresectionwithorwithoutmetastasectomyforleftandrightsidedstageivcolorectalcanceraninstrumentalvariableanalysis